EA201170353A1 - Антитела против гепатита с и их применение - Google Patents
Антитела против гепатита с и их применениеInfo
- Publication number
- EA201170353A1 EA201170353A1 EA201170353A EA201170353A EA201170353A1 EA 201170353 A1 EA201170353 A1 EA 201170353A1 EA 201170353 A EA201170353 A EA 201170353A EA 201170353 A EA201170353 A EA 201170353A EA 201170353 A1 EA201170353 A1 EA 201170353A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- hcv
- present
- provides
- antibodies
- conformational epitopes
- Prior art date
Links
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 241000711549 Hepacivirus C Species 0.000 abstract 1
- 101710125507 Integrase/recombinase Proteins 0.000 abstract 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Настоящее изобретение обеспечивает идентификацию и исследование характеристик конформационных эпитопов белка Е2 оболочки вируса гепатита С (ВГС). Настоящее изобретение обеспечивает набор моноклональных антител человека, распознающих конформационные эпитопы Е2. Эти антитела получены из пациентов, инфицированных ВГС. Настоящее изобретение обеспечивает способы использования антител к ВГС в качестве терапевтических, диагностических и/или профилактических агентов. Настоящее изобретение обеспечивает мимеотопы к интактным конформационным эпитопам и способы использования мимеотопов. Настоящее изобретение обеспечивает способы разделения пациентов на группы на основе их ответа на ВГС. Настоящее изобретение обеспечивает фармацевтические композиции для предотвращения и лечения ВГС, включающие одно или более антител к ВГС.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2008/078884 WO2010039154A1 (en) | 2008-10-05 | 2008-10-05 | Hepatitis c antibodies and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201170353A1 true EA201170353A1 (ru) | 2011-12-30 |
Family
ID=42073762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201170353A EA201170353A1 (ru) | 2008-10-05 | 2008-10-05 | Антитела против гепатита с и их применение |
Country Status (12)
Country | Link |
---|---|
US (1) | US8858947B2 (ru) |
EP (1) | EP2331573A4 (ru) |
JP (1) | JP2012504602A (ru) |
KR (1) | KR20110061624A (ru) |
CN (1) | CN102197050A (ru) |
AU (1) | AU2008362482A1 (ru) |
BR (1) | BRPI0823197A2 (ru) |
CA (1) | CA2738644A1 (ru) |
EA (1) | EA201170353A1 (ru) |
IL (1) | IL212040A0 (ru) |
MX (1) | MX2011003613A (ru) |
WO (1) | WO2010039154A1 (ru) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2778568A1 (en) | 2009-10-30 | 2011-05-05 | Toray Industries, Inc. | Antibody having activity of inhibiting hepatitis c virus (hcv) infection and use thereof |
WO2012107589A1 (en) * | 2011-02-11 | 2012-08-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of hcv infections |
WO2012151263A2 (en) * | 2011-05-02 | 2012-11-08 | The Johns Hopkins University | A synthetic hepatitis c genome and methods of making and use |
KR102165384B1 (ko) | 2012-08-07 | 2020-10-16 | 메사추세츠 인스티튜트 오브 테크놀로지 | 항-뎅기 바이러스 항체 및 이들의 용도 |
CN103172705B (zh) * | 2013-02-27 | 2014-08-20 | 北京大学人民医院 | 丙型肝炎病毒b细胞表位肽puhi16及其应用 |
CN103113458B (zh) * | 2013-02-27 | 2014-08-20 | 北京大学人民医院 | 丙型肝炎病毒b细胞表位肽puhi34及其应用 |
RU2539770C1 (ru) * | 2013-12-27 | 2015-01-27 | Татьяна Николаевна Власик | Способ нейтрализации вируса гепатита с, полностью человеческое моноклональное антитело против вируса гепатита с (варианты), композиция полностью человеческих моноклональных антител против вируса гепатита с и гибридная мышь/человек клеточная линия - продуцент полностью человеческих моноклональных антител против вируса гепатита с (варианты) |
AU2015217149B2 (en) * | 2014-02-11 | 2020-09-10 | Massachusetts Institute Of Technology | Novel full spectrum anti-dengue antibody |
JPWO2015133467A1 (ja) * | 2014-03-06 | 2017-04-06 | 株式会社シノテスト | C型肝炎ウイルスのワクチン及び診断に用いるためのHBc/HCV E2ペプチドキメラタンパク質 |
CN104327170A (zh) * | 2014-05-16 | 2015-02-04 | 中国疾病预防控制中心病毒病预防控制所 | 丙型肝炎病毒(hcv)细胞进入抑制肽zte1序列及应用 |
GB201415714D0 (en) * | 2014-09-05 | 2014-10-22 | Medical Res Council | Antibodies and antigen binding fragments thereof |
CN105254756B (zh) * | 2015-11-27 | 2018-09-07 | 武汉大学 | 一种针对丙型肝炎病毒包膜蛋白e2的单克隆抗体及应用 |
CN109641955B (zh) * | 2016-03-22 | 2022-07-08 | 国家医疗保健研究所 | 人源化抗claudin-1抗体及其用途 |
CN107011435B (zh) | 2016-06-01 | 2019-02-12 | 苏州银河生物医药有限公司 | 抗丙型肝炎病毒的全人单克隆抗体8d6 |
EP4095156A1 (en) * | 2021-05-28 | 2022-11-30 | Universität zu Köln | Neutralizing antibodies against hepatitis c virus |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1462300A (en) * | 1998-11-05 | 2000-05-22 | Board Of Trustees Of The Leland Stanford Junior University | Human pan-hcv human monoclonal antibodies |
US7091324B2 (en) | 1998-11-05 | 2006-08-15 | Board Of Trustees Of Leland Stanford Junior University | Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
CA2522379C (en) | 2003-04-10 | 2012-10-23 | Chiron Corporation | The severe acute respiratory syndrome coronavirus |
-
2008
- 2008-10-05 JP JP2011530033A patent/JP2012504602A/ja not_active Withdrawn
- 2008-10-05 US US13/122,598 patent/US8858947B2/en not_active Expired - Fee Related
- 2008-10-05 KR KR1020117008883A patent/KR20110061624A/ko not_active Application Discontinuation
- 2008-10-05 CN CN2008801313970A patent/CN102197050A/zh active Pending
- 2008-10-05 MX MX2011003613A patent/MX2011003613A/es unknown
- 2008-10-05 AU AU2008362482A patent/AU2008362482A1/en not_active Abandoned
- 2008-10-05 BR BRPI0823197-4A patent/BRPI0823197A2/pt not_active IP Right Cessation
- 2008-10-05 EP EP08824626A patent/EP2331573A4/en not_active Withdrawn
- 2008-10-05 EA EA201170353A patent/EA201170353A1/ru unknown
- 2008-10-05 CA CA2738644A patent/CA2738644A1/en not_active Abandoned
- 2008-10-05 WO PCT/US2008/078884 patent/WO2010039154A1/en active Application Filing
-
2011
- 2011-03-31 IL IL212040A patent/IL212040A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010039154A1 (en) | 2010-04-08 |
CN102197050A (zh) | 2011-09-21 |
BRPI0823197A2 (pt) | 2015-06-23 |
EP2331573A1 (en) | 2011-06-15 |
AU2008362482A1 (en) | 2010-04-08 |
EP2331573A4 (en) | 2012-09-05 |
KR20110061624A (ko) | 2011-06-09 |
CA2738644A1 (en) | 2010-05-08 |
JP2012504602A (ja) | 2012-02-23 |
MX2011003613A (es) | 2011-08-03 |
US20120039846A1 (en) | 2012-02-16 |
IL212040A0 (en) | 2011-06-30 |
US8858947B2 (en) | 2014-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201170353A1 (ru) | Антитела против гепатита с и их применение | |
WO2006041866A3 (en) | Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes | |
EA201071087A1 (ru) | Моноклональные антитела, способные взаимодействовать с множеством подтипов вируса гриппа а | |
EA201071365A1 (ru) | Моноклональные антитела, имеющие гомоподтип кросс-нейтрализующих свойств против вируса гриппа а подтипа н1 | |
EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
EA201390874A1 (ru) | Моноклональное антитело человека со специфичностью к белку e вируса денге серотипа 1 и его применение | |
EA201201116A1 (ru) | Моноклональные антитела человека, полученные из в-клеток человека и обладающие нейтрализующей активностью против вирусов гриппа а | |
EA200970586A1 (ru) | Антитела к цитомегаловирусу человека (hcmv) | |
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
EA201391170A1 (ru) | Терапевтическое средство на основе дрожжей для лечения хронического гепатита b | |
DE602005027258D1 (de) | Humane monoklonale antikörper gegen hendra- und nipah-viren | |
EA201270656A1 (ru) | Ингибиторы вируса гепатита с | |
EA200900297A1 (ru) | Ингибиторы вируса гепатита с | |
JP2010521147A5 (ru) | ||
CR8698A (es) | Anticuerpos monoclonales al factor de crecimiento de hepatocito | |
BR112014004860A2 (pt) | composições de anticorpo contra vírus da influenza | |
EA201000556A1 (ru) | Спиропирролидины и их применение для борьбы с инфицированием посредством hcv (вирус гепатита с) и вич (вирус иммунодефицита человека) | |
EA201000201A1 (ru) | Азотсодержащие бициклические химические вещества для лечения вирусных инфекций | |
MX2012001882A (es) | Anticuerpos contra el virus sincitial respiratorio (rsv) humano y metodos de uso. | |
EA201000644A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
EA201390806A1 (ru) | Конструкция пептидного каркаса | |
EA201370017A1 (ru) | Ингибиторы вируса гепатита с | |
BR0211296A (pt) | Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado | |
WO2009152147A3 (en) | Compositions and methods for dengue virus (dv) treatment and vaccination | |
EA201000277A1 (ru) | Соединения для лечения гепатита с |